Kiura, Katsuyuki - OU Author List - OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY

Plasma S100A8/A9 level predicts response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

FullText URL	fulltext.pdf
Author	Kuribayashi, Tadahiro\| Kinoshita, Rie\| Ninomiya, Kiichiro\| Makimoto, Go\| Kubo, Toshio\| Rai, Kammei\| Ichihara, Eiki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\| Toyooka, Shinichi\| Sakaguchi, Masakiyo\| Ohashi, Kadoaki\|
Keywords	S100A8/A9 Lung cancer Immune checkpoint inhibitors
Note	The version of record of this article, first published in Scientific Reports, is available online at Publisher’s website: http://dx.doi.org/10.1038/s41598-025-87232-z\|
Published Date	2025-01-20
Publication Title	Scientific Reports
Volume	volume15
Issue	issue1
Publisher	Nature Portfolio
Start Page	2577
ISSN	2045-2322
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© The Author(s) 2025
File Version	publisher
PubMed ID	39833332
DOI	10.1038/s41598-025-87232-z
Web of Science KeyUT	001400880600002
Related Url	isVersionOf https://doi.org/10.1038/s41598-025-87232-z

Frequency and Significance of Body Weight Loss During Immunochemotherapy in Patients with Advanced Non-Small Cell Lung Cancer

FullText URL	fulltext.pdf
Author	Taoka, Masataka\| Ichihara, Eiki\| Yokoyama, Toshihide\| Inoue, Koji\| Tamura, Tomoki\| Sato, Akiko\| Oda, Naohiro\| Kano, Hirohisa\| Nakamura, Kayo\| Kawai, Haruyuki\| Inoue, Masaaki\| Ochi, Nobuaki\| Fujimoto, Nobukazu\| Ichikawa, Hirohisa\| Ando, Chihiro\| Oze, Isao\| Kiura, Katsuyuki\| Maeda, Yoshinobu\| Hotta, Katsuyuki\|
Keywords	non-small cell lung cancer body weight loss immune checkpoint inhibitors chemotherapy
Published Date	2024-12-06
Publication Title	Cancers
Volume	volume16
Issue	issue23
Publisher	MDPI
Start Page	4089
ISSN	2072-6694
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2024 by the authors.
File Version	publisher
PubMed ID	39682275
DOI	10.3390/cancers16234089
Web of Science KeyUT	001376843000001
Related Url	isVersionOf https://doi.org/10.3390/cancers16234089

Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case report

FullText URL	fulltext.pdf
Author	Matsuura, Hiroaki\| Higo, Hisao\| Kuribayashi, Tadahiro\| Tamaoki, Akihiko\| Nakasuka, Takamasa\| Uno, Mari\| Makimoto, Go\| Ninomiya, Kiichiro\| Fujii, Masanori\| Rai, Kammei\| Ichihara, Eiki\| Hotta, Katsuyuki\| Miyahara, Nobuaki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\| Ohashi, Kadoaki\|
Keywords	case report EGFR-mutated lung cancer osimertinib pulmonary tuberculosis rifampicin
Published Date	2024-05-02
Publication Title	Thoracic Cancer
Volume	volume15
Issue	issue17
Publisher	Wiley
Start Page	1390
End Page	1394
ISSN	1759-7706
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2024 The Authors.
File Version	publisher
PubMed ID	38698706
DOI	10.1111/1759-7714.15324
Web of Science KeyUT	001216948400001
Related Url	isVersionOf https://doi.org/10.1111/1759-7714.15324

CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer

FullText URL	fulltext.pdf
Author	Hara, Naofumi\| Ichihara, Eiki\| Kano, Hirohisa\| Ando, Chihiro\| Morita, Ayako\| Nishi, Tatsuya\| Okawa, Sachi\| Nakasuka, Takamasa\| Hirabae, Atsuko\| Abe, Masaya\| Asada, Noboru\| Ninomiya, Kiichiro\| Makimoto, Go\| Fujii, Masanori\| Kubo, Toshio\| Ohashi, Kadoaki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	Epidermal growth factor receptor (EGFR) non-small cell lung cancer (NSCLC) cell cycle CDK4/6 inhibitor
Published Date	2023-10-31
Publication Title	Translational Lung Cancer Research
Volume	volume12
Issue	issue10
Publisher	AME Publishing Company
ISSN	2218-6751
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© Translational Lung Cancer Research.
File Version	publisher
PubMed ID	38025818
DOI	10.21037/tlcr-23-99
Web of Science KeyUT	001091030600001
Related Url	isVersionOf https://doi.org/10.21037/tlcr-23-99

The Roles of Neuropeptide Y in Respiratory Disease Pathogenesis via the Airway Immune Response

JaLCDOI	10.18926/AMO/66912
FullText URL	78_2_095.pdf
Author	Itano, Junko\| Kiura, Katsuyuki\| Maeda, Yoshinobu\| Miyahara, Nobuaki\|
Abstract	The lungs are very complex organs, and the respiratory system performs the dual roles of repairing tissue while protecting against infection from various environmental stimuli. Persistent external irritation disrupts the immune responses of tissues and cells in the respiratory system, ultimately leading to respiratory disease. Neuropeptide Y (NPY) is a 36-amino-acid polypeptide and a neurotransmitter that regulates homeostasis. The NPY receptor is a seven-transmembrane-domain G-protein-coupled receptor with six subtypes (Y1, Y2, Y3, Y4, Y5, and Y6). Of these receptors, Y1, Y2, Y4, and Y5 are functional in humans, and Y1 plays important roles in the immune responses of many organs, including the respiratory system. NPY and the Y1 receptor have critical roles in the pathogenesis of asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The effects of NPY on the airway immune response and pathogenesis differ among respiratory diseases. This review focuses on the involvement of NPY in the airway immune response and pathogenesis of various respiratory diseases.
Keywords	neuropeptide y Y1 receptor airway immune response bronchial epithelial cells respiratory disease
Amo Type	Review
Publication Title	Acta Medica Okayama
Published Date	2024-04
Volume	volume78
Issue	issue2
Publisher	Okayama University Medical School
Start Page	95
End Page	106
ISSN	0386-300X
NCID	AA00508441
Content Type	Journal Article
language	English
Copyright Holders	Copyright Ⓒ 2024 by Okayama University Medical School
File Version	publisher
Refereed	True
PubMed ID	38688827
Web of Science KeyUT	001229151800001

Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study

FullText URL	fulltext20240226-04.pdf
Author	Kuribayashi, Tadahiro\| Ohashi, Kadoaki\| Nishii, Kazuya\| Ninomiya, Kiichiro\| Tsubata, Yukari\| Ishikawa, Nobuhisa\| Kodani, Masahiro\| Kanaji, Nobuhiro\| Yamasaki, Masahiro\| Fujitaka, Kazunori\| Kuyama, Shoichi\| Takigawa, Nagio\| Fujimoto, Nobukazu\| Kubota, Tetsuya\| Inoue, Masaaki\| Fujiwara, Keiichi\| Harita, Shingo\| Takata, Ichiro\| Takada, Kenji\| Okawa, Sachi\| Kiura, Katsuyuki\| Hotta, Katsuyuki\|
Keywords	EGFR EGFR-TKI Lung cancer Immune checkpoint inhibitors Performance status
Note	The version of record of this article, first published in Journal of Cancer Research and Clinical Oncology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s00432-024-05618-4\|
Published Date	2024-02-12
Publication Title	Journal of Cancer Research and Clinical Oncology
Volume	volume150
Issue	issue2
Publisher	Springer Science and Business Media LLC
Start Page	89
ISSN	1432-1335
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© The Author(s) 2024
File Version	publisher
PubMed ID	38347279
DOI	10.1007/s00432-024-05618-4
Web of Science KeyUT	001160773600002
Related Url	isVersionOf https://doi.org/10.1007/s00432-024-05618-4

A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infection

FullText URL	fulltext.pdf
Author	Ichihara, Eiki\| Hasegawa, Kou\| Kudo, Kenichiro\| Tanimoto, Yasushi\| Nouso, Kazuhiro\| Oda, Naohiro\| Mitsumune, Sho\| Yamada, Haruto\| Takata, Ichiro\| Hagiya, Hideharu\| Mitsuhashi, Toshiharu\| Taniguchi, Akihiko\| Toyooka, Shinichi\| Tsukahara, Kohei\| Aokage, Toshiyuki\| Tsukahara, Hirokazu\| Kiura, Katsuyuki\| Maeda, Yoshinobu\|
Published Date	2023-10-26
Publication Title	PLoS ONE
Volume	volume18
Issue	issue10
Publisher	Public Library of Science
Start Page	e0287501
ISSN	1932-6203
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2023 Ichihara et al.
File Version	publisher
PubMed ID	37883347
DOI	10.1371/journal.pone.0287501
Web of Science KeyUT	001094123400028
Related Url	isVersionOf https://doi.org/10.1371/journal.pone.0287501

Massive hemoptysis in a post-operative patient with recurrent lung cancer successfully treated by the combination therapy of Endobronchial Watanabe Spigot and bronchial artery embolization

FullText URL	fulltext.pdf
Author	Taoka, Masataka\| Makimoto, Go\| Umakoshi, Noriyuki\| Ninomiya, Kiichiro\| Higo, Hisao\| Kato, Yuka\| Fujii, Masanori\| Kubo, Toshio\| Ichihara, Eiki\| Ohashi, Kadoaki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	Hemoptysis Bronchial artery embolization Endoscopic bronchial occlusion Endobronchial Watanabe Spigot
Published Date	2022
Publication Title	Respiratory Medicine Case Reports
Volume	volume38
Publisher	Elsevier
Start Page	101669
ISSN	2213-0071
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2022 The Authors.
File Version	publisher
PubMed ID	35646587
DOI	10.1016/j.rmcr.2022.101669
Web of Science KeyUT	001089212200003
Related Url	isVersionOf https://doi.org/10.1016/j.rmcr.2022.101669

Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies

FullText URL	fulltext20231004-03.pdf fig1_20231004-03.pdf fig2_20231004-03.pdf fig3_20231004-03.pdf fig4_20231004-03.pdf fig5_20231004-03.pdf Suppl20231004-03.pdf
Author	Kemmotsu, Naoya\| Ninomiya, Kiichiro\| Kunimasa, Kei\| Ishino, Takamasa\| Nagasaki, Joji\| Otani, Yoshihiro\| Michiue, Hiroyuki\| Ichihara, Eiki\| Ohashi, Kadoaki\| Inoue, Takako\| Tamiya, Motohiro\| Sakai, Kazuko\| Ueda, Youki\| Dansako, Hiromichi\| Nishio, Kazuto\| Kiura, Katsuyuki\| Date, Isao\| Togashi, Yosuke\|
Keywords	cancer immunotherapy intracranial metastasis intracranial progression memory precursor effector T cell nonsmall-cell lung cancer
Note	This is the peer reviewed version of the following article: [Kemmotsu N, Ninomiya K, Kunimasa K, et al. Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapies. Int J Cancer. 2024; 154(1): 169-179. doi:10.1002/ijc.34700], which has been published in final form at [https://doi.org/10.1002/ijc.34700]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.\| This fulltext file will be available in Aug. 2024.\|
Published Date	2023-08-23
Publication Title	International Journal of Cancer
Volume	volume154
Issue	issue1
Publisher	Wiley
Start Page	169
End Page	179
ISSN	0020-7136
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2023 UICC.
File Version	author
PubMed ID	37611176
DOI	10.1002/ijc.34700
Web of Science KeyUT	001069876600001
Related Url	isVersionOf https://doi.org/10.1002/ijc.34700

Efficacy of gilteritinib in comparison with alectinib for the treatment of ALK-rearranged non-small cell lung cancer

FullText URL	fulltext.pdf
Author	Ando, Chihiro\| Ichihara, Eiki\| Nishi, Tatsuya\| Morita, Ayako\| Hara, Naofumi\| Takada, Kenji\| Nakasuka, Takamasa\| Watanabe, Hiromi\| Kano, Hirohisa\| Nishii, Kazuya\| Makimoto, Go\| Kondo, Takumi\| Ninomiya, Kiichiro\| Fujii, Masanori\| Kubo, Toshio\| Ohashi, Kadoaki\| Matsuoka, Ken-Ichi\| Hotta, Katsuyuki\| Tabata, Masahiro\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	alectinib ALK gilteritinib non-small cell lung cancer TKI
Published Date	2023-09-15
Publication Title	Cancer Science
Volume	volume114
Issue	issue11
Publisher	Wiley
Start Page	4343
End Page	4354
ISSN	1347-9032
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2023 The Authors.
File Version	publisher
PubMed ID	37715310
DOI	10.1111/cas.15958
Web of Science KeyUT	001067479000001
Related Url	isVersionOf https://doi.org/10.1111/cas.15958

Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study

FullText URL	fulltext.pdf
Author	Higo, Hisao\| Ichikawa, Hirohisa\| Arakawa, Yukako\| Mori, Yoshihiro\| Itano, Junko\| Taniguchi, Akihiko\| Senoo, Satoru\| Kimura, Goro\| Tanimoto, Yasushi\| Miyake, Kohei\| Katsuta, Tomoya\| Kataoka, Mikio\| Maeda, Yoshinobu\| Kiura, Katsuyuki\| Miyahara, Nobuaki\| Okayama Respiratory Disease Study Group (ORDSG)\|
Keywords	dupilumab severe asthma treatment interval eosinophilic chronic rhinosinusitis
Published Date	2023-08-09
Publication Title	Journal of Clinical Medicine
Volume	volume12
Issue	issue16
Publisher	MDPI
Start Page	5174
ISSN	2077-0383
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2023 by the authors.
File Version	publisher
PubMed ID	37629217
DOI	10.3390/jcm12165174
Web of Science KeyUT	001056259200001
Related Url	isVersionOf https://doi.org/10.3390/jcm12165174

Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

FullText URL	fulltext.pdf
Author	Morinaga, Takao\| Inozume, Takashi\| Kawazu, Masahito\| Ueda, Youki\| Sax, Nicolas\| Yamashita, Kazuo\| Kawashima, Shusuke\| Nagasaki, Joji\| Ueno, Toshihide\| Lin, Jason\| Ohara, Yuuki\| Kuwata, Takeshi\| Yukami, Hiroki\| Kawazoe, Akihito\| Shitara, Kohei\| Honobe-Tabuchi, Akiko\| Ohnuma, Takehiro\| Kawamura, Tatsuyoshi\| Umeda, Yoshiyasu\| Kawahara, Yu\| Nakamura, Yasuhiro\| Kiniwa, Yukiko\| Morita, Ayako\| Ichihara, Eiki\| Kiura, Katsuyuki\| Enokida, Tomohiro\| Tahara, Makoto\| Hasegawa, Yoshinori\| Mano, Hiroyuki\| Suzuki, Yutaka\| Nishikawa, Hiroyoshi\| Togashi, Yosuke\|
Published Date	2022-07-28
Publication Title	Cancer Research Communications
Volume	volume2
Issue	issue7
Publisher	American Association for Cancer Research
Start Page	739
End Page	753
ISSN	2767-9764
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2022 The Authors
File Version	publisher
PubMed ID	36923281
DOI	10.1158/2767-9764.CRC-22-0050
Web of Science KeyUT	001048412300001
Related Url	isVersionOf https://doi.org/10.1158/2767-9764.CRC-22-0050

Chemo-preventive effects and antitumorigenic mechanisms of beer and nonalcoholic beer toward 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in A/J mice

FullText URL	fulltext.pdf
Author	Takata, Jun\| Kiura, Katsuyuki\| Nakasuka, Takamasa\| Hirabae, Atsuko\| Arimoto-Kobayashi, Sakae\|
Keywords	Anti-mutagenesis Signal transduction Lung tumorigenesis DNA methylation Tobacco-specific nitrosamine Glycine betaine
Note	The version of record of this article, first published in Genes and Environment, is available online at Publisher’s website: http://dx.doi.org/10.1186/s41021-023-00276-3\|
Published Date	2023-06-07
Publication Title	Genes and Environment
Volume	volume45
Issue	issue1
Publisher	BMC
Start Page	19
ISSN	1880-7046
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© The Author(s) 2023.
File Version	publisher
PubMed ID	37280663
DOI	10.1186/s41021-023-00276-3
Web of Science KeyUT	001002195100001
Related Url	isVersionOf https://doi.org/10.1186/s41021-023-00276-3

Fulminant Myocarditis for Non-small-cell Carcinoma of the Lung with Nivolumab and Ipilimumab Plus Chemotherapy

FullText URL	fulltext.pdf
Author	Nishimura, Tomoka\| Ninomiya, Kiichiro\| Nakashima, Mitsutaka\| Akagi, Satoshi\| Kuribayashi, Tadahiro\| Higo, Hisao\| Hotta, Katsuyuki\| Maeda, Yoshinobu\| Ito, Hiroshi\| Kiura, Katsuyuki\|
Keywords	myocarditis nivolumab plus ipilimumab irAE case report
Published Date	2023-05-01
Publication Title	Internal Medicine
Volume	volume62
Issue	issue9
Publisher	The Japanese Society of Internal Medicine
Start Page	1319
End Page	1322
ISSN	0918-2918
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2023 The Japanese Society of Internal Medicine
File Version	publisher
PubMed ID	36130891
DOI	10.2169/internalmedicine.0505-22
Web of Science KeyUT	000988462100001
Related Url	isVersionOf https://doi.org/10.2169/internalmedicine.0505-22

PD-1 blockade augments CD8+ T cell dependent antitumor immunity triggered by Ad-SGE-REIC in Egfr-mutant lung cancer

FullText URL	fulltext20230421-01.pdf figure20230421-01.pdf
Author	Nakasuka, Takamasa\| Ohashi, Kadoaki\| Nishii, Kazuya\| Hirabae, Atsuko\| Okawa, Sachi\| Tomonobu, Nahoko\| Takada, Kenji\| Ando, Chihiro\| Watanabe, Hiromi\| Makimoto, Go\| Ninomiya, Kiichiro\| Fujii, Masanori\| Kubo, Toshio\| Ichihara, Eiki\| Hotta, Katsuyuki\| Tabata, Masahiro\| Kumon, Hiromi\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	EGFR mutation Non-small cell lung cancer Antitumor immunity Non-inflamed tumor Ad-SGE-REIC Gene therapy PD-1
Note	©2023 Elsevier B.V. This manuscript version is made available under the CC-BY-NC-ND 4.0 License. http://creativecommons.org/licenses/by-nc-nd/4.0/. This is the accepted manuscript version. The formal published version is available at https://doi.org/10.1016/j.lungcan.2023.01.018.\| This fulltext file will be available in Apr. 2024.\|
Published Date	2023-04
Publication Title	Lung Cancer
Volume	volume178
Publisher	Elsevier BV
Start Page	1
End Page	10
ISSN	0169-5002
NCID	AA10785743
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2023 Elsevier B.V.
File Version	author
PubMed ID	36753780
DOI	10.1016/j.lungcan.2023.01.018
Web of Science KeyUT	000931976300001
Related Url	isVersionOf https://doi.org/10.1016/j.lungcan.2023.01.018

Bladder tuberculosis with ureteral strictures after bacillus Calmette‑Guérin therapy for urinary bladder cancer: A case report

FullText URL	fulltext20230317-1.pdf
Author	Tominaga, Yusuke\| Fujii, Masanori\| Sadahira, Takuya\| Katayama, Satoshi\| Iwata, Takehiro\| Nishimura, Shingo\| Bekku, Kensuke\| Edamura, Kohei\| Kobayashi, Tomoko\| Kobayashi, Yasuyuki\| Kiura, Katsuyuki\| Maeda, Yoshinobu\| Wada, Koichiro\| Araki, Motoo\|
Keywords	bladder tuberculosis bacillus Calmette-Guerin bladder cancer ureteral stricture voiding dysfunction
Published Date	2022-12-20
Publication Title	Molecular and Clinical Oncology
Volume	volume18
Issue	issue2
Publisher	Spandidos Publications
Start Page	7
ISSN	2049-9450
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© Tominaga et al.
File Version	publisher
PubMed ID	36761388
DOI	10.3892/mco.2022.2603
Web of Science KeyUT	000928771000001
Related Url	isVersionOf https://doi.org/10.3892/mco.2022.2603

Effect of a Cyclooxygenase-2 Inhibitor in Combination with (−)-Epigallocatechin Gallate or Polyphenon E on Cisplatin-Induced Lung Tumorigenesis in A/J Mice

JaLCDOI	10.18926/AMO/64363
FullText URL	77_1_65.pdf
Author	Sato, Ken\| Takigawa, Nagio\| Kubo, Toshio\| Katayama, Hideki\| Kishino, Daizo\| Okada, Toshiaki\| Hisamoto, Akiko\| Mimoto, Junko\| Ochi, Nobuaki\| Yoshino, Tadashi\| Ueoka, Hiroshi\| Tanimoto, Mitsune\| Maeda, Yoshionobu\| Kiura, Katsuyuki\|
Abstract	We investigated the effects of celecoxib combined with (−)-epigallocatechin-3-gallate (EGCG) or polyphenon E in a cisplatin-induced lung tumorigenesis model. Four-week-old female A/J mice were divided into seven groups: (i) Control, (ii) 150 mg/kg celecoxib (150Cel), (iii) 1,500 mg/kg celecoxib (1500Cel), (iv) EGCG+150 mg/kg celecoxib (EGCG+150Cel), (v) EGCG+1,500 mg/kg celecoxib (EGCG+1500Cel), (vi) polyphenon E+150 mg/kg celecoxib (PolyE+150Cel), and (vii) polyphenon E+1,500 mg/kg celecoxib (PolyE+1500Cel). All mice were administered cisplatin (1.62 mg/kg of body weight, i.p.) 1×/week for 10 weeks and sacrificed at week 30; the numbers of tumors on the lung surface were then determined. The tumor incidence and multiplicity (no. of tumors/mouse, mean±SD) were respectively 95% and 2.15±1.50 in Control, 95% and 2.10±1.29 in 150Cel, 86% and 1.67±1.20 in 1500Cel, 71% and 1.38±1.24 in EGCG+150Cel, 67% and 1.29±1.38 in EGCG+1500Cel, 80% and 1.95±1.36 in PolyE+150Cel, and 65% and 1.05±0.10 in PolyE+1500Cel. The combination of high-dose celecoxib with EGCG or polyphenon E significantly reduced multiplicity in cisplatin-induced lung tumors.
Keywords	celecoxib cisplatin EGCG lung tumor polyphenon E
Amo Type	Original Article
Publication Title	Acta Medica Okayama
Published Date	2023-02
Volume	volume77
Issue	issue1
Publisher	Okayama University Medical School
Start Page	65
End Page	70
ISSN	0386-300X
NCID	AA00508441
Content Type	Journal Article
language	English
Copyright Holders	Copyright Ⓒ 2023 by Okayama University Medical School
File Version	publisher
Refereed	True
PubMed ID	36849147
Web of Science KeyUT	000952992100004

The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study

FullText URL	fulltext.pdf
Author	Nishimura, Tomoka\| Ichihara, Eiki\| Yokoyama, Toshihide\| Inoue, Koji\| Tamura, Tomoki\| Sato, Ken\| Oda, Naohiro\| Kano, Hirohisa\| Kishino, Daizo\| Kawai, Haruyuki\| Inoue, Masaaki\| Ochi, Nobuaki\| Fujimoto, Nobukazu\| Ichikawa, Hirohisa\| Ando, Chihiro\| Hotta, Katsuyuki\| Maeda, Yoshinobu\| Kiura, Katsuyuki\|
Keywords	pleural effusion non-small cell carcinoma immune checkpoint inhibitors
Published Date	2022-12-14
Publication Title	Cancers
Volume	volume14
Issue	issue24
Publisher	MDPI
Start Page	6184
ISSN	2072-6694
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2022 by the authors.
File Version	publisher
PubMed ID	36551668
DOI	10.3390/cancers14246184
Web of Science KeyUT	000900618600001
Related Url	isVersionOf https://doi.org/10.3390/cancers14246184

Chemopreventive effects and anti-tumorigenic mechanisms of Actinidia arguta, known as sarunashi in Japan toward 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)- induced lung tumorigenesis in a/J mouse

FullText URL	fulltext20221227-2.pdf
Author	Takata, Jun\| Miyake, Naoko\| Saiki, Yusuke\| Tada, Misako\| Sasaki, Kensuke\| Kubo, Toshio\| Kiura, Katsuyuki\| Arimoto-Kobayashi, Sakae\|
Keywords	Akt signal transduction Lung tumorigenesis Anti-mutagenesis DNA methylation Tobacco-specific nitrosamine Isoquercetin
Published Date	2022-12-09
Publication Title	Genes and Environment
Volume	volume44
Issue	issue1
Publisher	Springer Science and Business Media LLC
Start Page	26
ISSN	1880-7062
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© The Author(s) 2022.
File Version	publisher
PubMed ID	36494703
DOI	10.1186/s41021-022-00255-0
Web of Science KeyUT	000896571200001
Related Url	isVersionOf https://doi.org/10.1186/s41021-022-00255-0

Neuropeptide Y Antagonizes Development of Pulmonary Fibrosis through IL-1β Inhibition

FullText URL	fulltext20221223-3.pdf NA_Itano_Fig.pdf supl20221223-3.pdf NA_Itano_Supl.pdf
Author	Itano, Junko\| Taniguchi, Akihiko\| Senoo, Satoru\| Asada, Noboru\| Gion, Yuka\| Egusa, Yuria\| Guo, Lili\| Oda, Naohiro\| Araki, Kota\| Sato, Yasuharu\| Toyooka, Shinichi\| Kiura, Katsuyuki\| Maeda, Yoshinobu\| Miyahara, Nobuaki\|
Keywords	idiopathic pulmonary fibrosis NPY IL-1 beta; bleomycin bronchial epithelial cells
Note	Originally Published in:Itano J, Taniguchi A, Senoo S, Asada N, Gion Y, Egusa Y, Guo L, Oda N, Araki K, Sato Y, Toyooka S, Kiura K, Maeda Y, Miyahara N. Neuropeptide Y Antagonizes Development of Pulmonary Fibrosis through IL-1β Inhibition. Am J Respir Cell Mol Biol. 2022 Dec;67(6):654-665. DOI: 10.1165/rcmb.2021-0542OC Copyright © 2022 by the American Thoracic Society The final publication is available at https://doi.org/10.1165/rcmb.2021-0542OC \| This full-text will be available in Dec. 2023.\|
Published Date	2022-12
Publication Title	American Journal of Respiratory Cell and Molecular Biology
Volume	volume67
Issue	issue6
Publisher	American Thoracic Society
Start Page	654
End Page	665
ISSN	1044-1549
NCID	AA10707251
Content Type	Journal Article
language	English
OAI-PMH Set	岡山大学
Copyright Holders	© 2022 by the American Thoracic Society
File Version	author
PubMed ID	36122332
DOI	10.1165/rcmb.2021-0542oc
Web of Science KeyUT	000891796900010
Related Url	isVersionOf https://doi.org/10.1165/rcmb.2021-0542oc